Histiocytic Sarcoma Review, Discussion of Transformation From B-Cell Lymphoma, and Differential Diagnosis

被引:55
作者
Skala, Stephanie L. [1 ]
Lucas, David R. [1 ]
Dewar, Rajan [1 ]
机构
[1] Univ Michigan, Dept Pathol, 1301 Catherine St,5242 Med Sci 1, Ann Arbor, MI 48109 USA
关键词
CHRONIC-LYMPHOCYTIC-LEUKEMIA; DENDRITIC CELL; FOLLICULAR LYMPHOMAS; PATIENT; NEOPLASMS; TRANSDIFFERENTIATION; DISEASE; TUMORS; CLL;
D O I
10.5858/arpa.2018-0220-RA
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Context.-Histiocytic sarcoma is a rare neoplasm of mature histiocytes with an aggressive clinical course that can arise de novo or from a low-grade B-cell lymphoma. In particular, chronic lymphocytic leukemia/small lymphocytic lymphoma is a very common malignancy in the Western hemisphere, and most cases of chronic lymphocytic leukemia/small lymphocytic lymphoma have an indolent course and behavior. However, 2% to 8% of chronic lymphocytic leukemia/small lymphocytic lymphoma cases transform. Histiocytic sarcomatous transformation is rare and portends poor prognosis. Objective.-To review the clinical features, morphology, and key points related to the differential diagnosis for histiocytic sarcoma. We discuss recent understanding of the biology underlying transformation. Data Sources.-University of Michigan case and review of pertinent literature about histiocytic sarcoma and morphologic differential diagnosis. Conclusions.-Histiocytic sarcoma is a rare histiocytic neoplasm that can arise as a result of transdifferentiation from low-grade B-cell lymphomas, and has a wide differential diagnosis including other histiocytic/dendritic cell neoplasms, myeloid neoplasms, lymphomas, melanoma, and carcinoma. However, some key morphologic and immunohistochemical features allow for accurate classification.
引用
收藏
页码:1322 / 1329
页数:8
相关论文
共 44 条
[1]   True histiocytic lymphoma of the stomach associated with low-grade B-cell mucosa-associated lymphoid tissue (Malt)-type lymphoma [J].
Alvaro, T ;
Bosch, R ;
Salvado, MT ;
Piris, MA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (11) :1406-1411
[2]  
[Anonymous], 2017, WHO CLASSIFICATION T
[3]   Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment [J].
Ansari, Junaid ;
Naqash, Abdul Rafeh ;
Munker, Reinhold ;
El-Osta, Hazem ;
Master, Samip ;
Cotelingam, James D. ;
Griffiths, Elizabeth ;
Greer, Adam H. ;
Yin, Hong ;
Peddi, Prakash ;
Shackelford, Rodney E. .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (01) :9-16
[4]  
BENYEHUDASALZ D, 1990, CANCER-AM CANCER SOC, V65, P1167, DOI 10.1002/1097-0142(19900301)65:5<1167::AID-CNCR2820650523>3.0.CO
[5]  
2-V
[6]  
Chen Weiwei, 2013, N Am J Med Sci, V5, P386, DOI 10.4103/1947-2714.114172
[7]  
DELSOL G, 1988, AM J PATHOL, V130, P59
[8]   Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases [J].
Facchetti, Fabio ;
Pileri, Stefano Aldo ;
Lorenzi, Luisa ;
Tabanelli, Valentina ;
Rimsza, Lisa ;
Pittaluga, Stefania ;
Dirnhofer, Stephan ;
Copie-Bergman, Christiane ;
de Leval, Laurence ;
Rosenwald, Andreas ;
Wotherspoon, Andrew ;
Fend, Falko .
VIRCHOWS ARCHIV, 2017, 471 (04) :467-489
[9]  
FALINI B, 1980, CANCER-AM CANCER SOC, V46, P1140, DOI 10.1002/1097-0142(19800901)46:5<1140::AID-CNCR2820460511>3.0.CO
[10]  
2-B